| 12.09 16:45 | dpa-AFX: Perrigo Prices Senior Notes Offering Due 2032 Through Finance Subsidiary |
| 12.09 15:04 | dpa-AFX: *PERRIGO PRICES SENIOR NOTES OFFERING THROUGH FINANCE SUBSIDIARY PERRIGO FINANCE UNLIMITED COMPANY |
| 10.09 16:04 | dpa-AFX: Perrigo To Present At Piper Sandler Growth Frontiers Conference; Webcast At 11:00 AM ET |
| 09.08 13:29 | dpa-AFX: Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula |
| 09.08 12:33 | dpa-AFX: *PERRIGO ISSUES VOLUNTARY RECALL OF ONE BATCH OF PREMIUM INFANT FORMULA WITH IRON MILK-BASED POWDER DUE TO ELEVATED LEVELS OF VITAMIN D |
| 02.08 13:54 | dpa-AFX: Perrigo Reaffirms FY24 Adj. EPS Guidance; Updates Sales Outlook |
| 02.08 13:30 | dpa-AFX: Perrigo Q2 24 Earnings Conference Call At 8:30 AM ET |
| 02.08 12:43 | dpa-AFX: Perrigo Company Plc Q2 Earnings Summary |
| 02.08 12:38 | dpa-AFX: *PERRIGO REAFFIRMS 2024 ADJ EPS OUTLOOK OF $2.50-$2.65 |
| 02.08 12:38 | dpa-AFX: *PERRIGO UPDATES 2024 ORGANIC NET SALES GROWTH OUTLOOK TO -3% TO -1% |
| 02.08 12:37 | dpa-AFX: *PERRIGO Q2 GAAP OPERATING LOSS $27 MLN; ADJUSTED OPERATING INCOME $139 MLN |
| 02.08 12:37 | dpa-AFX: *PERRIGO Q2 ORGANIC NET SALES DECREASE 9.1% |
| 02.08 12:36 | dpa-AFX: *PERRIGO Q2 NET SALES DOWN 10.7% TO $1.1 BLN |
| 02.08 12:33 | dpa-AFX: *PERRIGO Q2 LOSS PER SHARE $0.77; ADJ EPS $0.53 |
| 01.08 15:17 | dpa-AFX: *PERRIGO COMPANY PLC (PRGO) DECLARES QUARTERLY DIVIDEND OF $ 0.276 , RECORD DATE 8/30/2024 |
| 01.08 15:01 | dpa-AFX: *PERRIGO DECLARES QUARTERLY DIVIDEND OF $0.276/SHR, PAYABLE SEPT. 17, RECORD AUG. 10 |
| 10.07 14:03 | dpa-AFX: *PERRIGO CLOSES DIVESTMENT OF HRA PHARMA RARE DISEASES BUSINESS |
| 07.05 13:32 | dpa-AFX: Perrigo Q1 24 Earnings Conference Call At 8:30 AM ET |
| 07.05 12:51 | dpa-AFX: ROUNDUP: Perrigo Reaffirms 2024 Outlook |
| 07.05 12:37 | dpa-AFX: *PERRIGO REAFFIRMS 2024 ADJ. EPS OUTLOOK OF $2.50-$2.65 |
|
|
